Previous close | 40.48 |
Open | 41.03 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 41.03 - 41.03 |
52-week range | 41.03 - 41.03 |
Volume | |
Avg. volume | N/A |
Market cap | 23.229M |
Beta (5Y monthly) | 0.84 |
PE ratio (TTM) | 4.61 |
EPS (TTM) | 0.09 |
Earnings date | 22 Feb 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
With that in mind, let's look at two growth stocks that fit the bill: Tandem Diabetes Care (NASDAQ: TNDM) and Fiverr (NYSE: FVRR). Medical device specialist Tandem Diabetes Care focuses on the diabetes market, as its name suggests. The company has been an innovator in the field, and right now, it makes money by selling its prized insulin pump, the t:slim X2.
SAN DIEGO, January 23, 2023--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced the completion of its previously announced acquisition of AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump. The Sigi Patch Pump, designed to be an ergonomic, rechargeable patch pump that reduces the burden of managing diabetes through its use of pre-filled insulin cartridges, is under development and not commercially available
SAN DIEGO, January 19, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2022 results after the financial markets close on Wednesday, February 22, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2022 financial and operating results.